ECOG: The Eastern Cooperative Oncology Group

General Information
 

ECOG-ACRIN
  ECOG-ACRIN web site

Clinical Trials
  Guide For Cancer Patients
  What is a clinical trial?
  Why participate?
  Does insurance cover costs?
  What if I change my mind?
  How can I join a clinical trial?
  Active protocols
 Educational Materials
  Selenium E5597
  GI Studies E4203,E5204
  GI E1208
  Head & Neck Cancer E1305
  Leukemia E1910
  Leukemia E1912
  Lung Cancer E1505
  Lung Cancer E5508
  Lymphoma E2410
  Melanoma E1609
  Melanoma E2603
  Prostate CHAARTED E3805
  Cancer in Siblings E1Y97
  Non-Hodgkins Lymphoma E4402
  Breast E2108
  Breast Cancer PACCT1: TAILORx
  Informational Videos
  Trial Summary Results

Pathology and
Laboratory Science

  Pathology and Lab Science

Trial Monitoring
  Data Safety Monitoring Committee

Member Institutions
  Institutions by state
  Alphabetical listing

Become a Member
  Joining ECOG-ACRIN

Publications
  Publications bibliography
 
Announcements
  Job Openings
  Future Group Meeting Dates

Scales and Criteria
  ECOG Performance Status
  Common Toxicity Criteria

Cancer Information
  Colon Cancer Video
  Cancer Survivor Publications
  Releasing Results Guidelines

Other Cancer Sites
  Main Institutions' Sites
  Other Cooperative Groups
  Advocates/Support Groups
  PrECOG, LLC
 

ECOG HOME PAGE

MEMBERS
INFORMATION

(password required)

GLOSSARY

SEARCH

CONTACT INFORMATION

DISCLAIMER

                    

Introduction to ECOG


The Eastern Cooperative Oncology Group (ECOG) was established in 1955 as one of the first cooperative groups launched to perform multi-center cancer clinical trials. A cooperative group is a large network of researchers, physicians, and health care professionals at public and private institutions across the country who are members of the group. Funded primarily by the National Cancer Institute (NCI), ECOG has evolved from a five member consortium of institutions on the East Coast to one of the largest clinical cancer research organizations in the U.S. with almost 6000 physicians, nurses, pharmacists, statisticians, and clinical research associates (CRAs) from the U.S., Canada, and South Africa. Institutional members include universities, medical centers, Community Clinical Oncology Programs (CCOPs), and Cooperative Group Outreach Programs (CGOPs). These institutions work toward the common goal of controlling, effectively treating, and ultimately curing cancer. Research results are provided to the world-wide medical community through scientific publications and professional meetings.

Currently, ECOG has more than 90 active clinical trials in all types of adult malignancies. Annual accrual is 6,000 patients, with more than 20,000 patients in follow-up.

Examples of ECOG clinical trials that have changed or improved cancer treatment methods include:

  • A study that establishes an effective chemotherapy regimen in acute promyelocytic leukemia.
  • A study that demonstrated that a less-toxic regimen had similar results to the standard treatment of metastatic nonsmall cell lung cancer.
  • A study that demonstrated that an intensive bone marrow transplant regimen for patients with metastatic breast cancer who responded to inital standard chemotherapy did not improve time to disease progression or lifetime survival.
  • A study that establishes an effective treatment program involving chemotherapy and radiation therapy for early lung cancer.

Next page


How to contact ECOG

All contents copyright © 1998-2000 Eastern Cooperative Oncology Group.
All rights reserved.
Revised: June 6, 2006